$Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkins lymphomas : a systematic review and economic evaluation$
Cover image not available

Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkins lymphomas : a systematic review and economic evaluation

Publication Data

Title Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkins lymphomas : a systematic review and economic evaluation
Contributors B. Wake, National Co-ordinating Centre for HTA
Publisher Core Research on behalf of the NCCHTA
Publication date 2002
Publication location Alton
Language English

Topics

Rituximab
Lymphomas :: Immunotherapy

Catalogue Data

OBNB ID GBA236110
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99442

ISBD

P1053 iv, 85 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkins lymphomas : a systematic review and economic evaluation. Published by Core Research on behalf of the NCCHTA in 2002. Publication and catalogue information, links to buy online and reader comments.